logo

For the Inventor, By the Inventor

Bekescsaba, Hungary

Tamás Solymosi

This inventor holds 11 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Druggability Technologies IP Holdco Limited, Nangenex Nanotechnology Incorporated, Tavanta Therapeutics Hungary Incorporated. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamás Solymosi. Retrieved from https://idiyas.com/inventor/tamás-solymosi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 54.5

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal6 out of 10 
 
Druggability Technologies IP Holdco Limited
 patents
silverMedal3 out of 3 
 
Nangenex Nanotechnology Incorporated
 patents
bronzeMedal2 out of 2 
 
Tavanta Therapeutics Hungary Incorporated
 patents

Years Active: 2017-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 11766428 - Topical amlodipine salts for the treatment of anorectal diseases (2023-09-26),
2. 11197848 - Topical amlodipine salts for the treatment of anorectal diseases (2021-12-14),
3. 10688110 - Complexes of Celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them (2020-06-23),
4. 10675277 - Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them (2020-06-09),
5. 10668016 - Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them (2020-06-02),
6. 10500202 - Pharmaceutical formulation containing tadalafil (2019-12-10),
7. 10307429 - Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them (2019-06-04),
8. 10206915 - Complexes of Ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them (2019-02-19),
9. 10130582 - Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them (2018-11-20),
10. 9623034 - Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them (2017-04-18),
11. 9592244 - Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them (2017-03-14),

Title: The Innovative Contributions of Tamás Solymosi

Introduction

Tamás Solymosi is a notable inventor based in Bekescsaba, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of anorectal diseases. With a total of 11 patents to his name, Solymosi's work has garnered attention for its innovative approaches and practical applications.

Latest Patents

Among his latest patents, Solymosi has developed topical amlodipine salts specifically designed for the treatment of anorectal diseases. This invention includes a topical pharmaceutical gel composition that utilizes an amlodipine salt, along with methods for its effective use in treating such conditions. His work in this area demonstrates a commitment to improving patient care through innovative pharmaceutical solutions.

Career Highlights

Throughout his career, Tamás Solymosi has worked with various companies, including Druggability Technologies IP Holdco Limited and Nangenex Nanotechnology Incorporated. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Solymosi has collaborated with several professionals in his field, including Hristos Glavinas and Tamás Jordán. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Tamás Solymosi's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his dedication to advancing medical treatments. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…